Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Terumo Cardiovascular Systems Corporation - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7116
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. Its major products include autotransfusion products, beating heart products, cannulae, endoscopic products, monitoring systems, perfusion products, platelet therapy, sternotomy products, surgical stabilization products and vascular grafts. The company has manufacturing facilities in the US, the UK and Japan. The company distributes its products across North America, Europe, Asia, Australia, the Middle East, Africa, South and Central America regions. TCSC is headquartered in Ann Arbor, Michigan, the US.

Terumo Cardiovascular Systems Corporation – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Terumo Cardiovascular Systems Corporation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deal Details 10
Asset Purchase 10
Terumo Acquires Orpheus Simulator Technology From Ulco Technologies 10
Partnerships 11
Terumo Cardiovascular Systems Expands Distribution Agreement with Nonin Medical for SenSmart Model X-100 Universal Oximetry System 11
Terumo Cardiovascular Systems Enters Into Distribution Agreement With Nonin Medical 12
Terumo Cardiovascular Enters Into Distribution Agreement With LAAx 13
Asset Transactions 14
MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems 14
Terumo Cardiovascular Systems Corporation – Key Competitors 15
Terumo Cardiovascular Systems Corporation – Key Employees 16
Terumo Cardiovascular Systems Corporation – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Terumo Cardiovascular Systems Corporation, Medical Equipment, Key Facts 2
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Terumo Cardiovascular Systems Corporation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Terumo Cardiovascular Systems Corporation, Deals By Market, 2012 to YTD 2018 8
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Terumo Acquires Orpheus Simulator Technology From Ulco Technologies 10
Terumo Cardiovascular Systems Expands Distribution Agreement with Nonin Medical for SenSmart Model X-100 Universal Oximetry System 11
Terumo Cardiovascular Systems Enters Into Distribution Agreement With Nonin Medical 12
Terumo Cardiovascular Enters Into Distribution Agreement With LAAx 13
MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems 14
Terumo Cardiovascular Systems Corporation, Key Competitors 15
Terumo Cardiovascular Systems Corporation, Key Employees 16
Terumo Cardiovascular Systems Corporation, Other Locations 17

List of Figures
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Terumo Cardiovascular Systems Corporation, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saras S.p.A. (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras S.p.A. (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industri …
  • Sto SE & Co KGaA:企業の戦略・SWOT・財務情報
    Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Sto SE & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Banco do Brasil SA:企業のM&A・事業提携・投資動向
    Banco do Brasil SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco do Brasil SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • TaiwanJ Pharmaceuticals Co Ltd (6549):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiwanJ Pharmaceuticals Co Ltd (TaiwanJ) is a pharmaceutical company that develops and commercialize small molecules for unmet medical needs such as chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It develops TLR4, a transmembrane protein that provides key medi …
  • HDFC Standard Life Insurance Company Limited:企業のM&A・事業提携・投資動向
    HDFC Standard Life Insurance Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Standard Life Insurance Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Calamos Asset Management, Inc.
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 …
  • ENN Energy Holdings Ltd (2688):企業の財務・戦略的SWOT分析
    ENN Energy Holdings Ltd (2688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • X4 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a pharmaceutical company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiency disease. It also de …
  • ReproCELL Inc (4978):企業の財務・戦略的SWOT分析
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • MolecularMD Corp:医療機器:M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • WEX Pharmaceuticals Inc:企業の戦略的SWOT分析
    WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Goodrich Petroleum Corp (GDP):企業の財務・戦略的SWOT分析
    Goodrich Petroleum Corp (GDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Straco Corporation Limited:戦略・SWOT・企業財務分析
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CooperVision Inc:製品パイプライン分析
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Galderma SA:企業の戦略的SWOT分析
    Galderma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Celina Insurance Group:企業の戦略・SWOT・財務分析
    Celina Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Celina Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Buckeye Partners, L.P.:企業の戦略・SWOT・財務情報
    Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cott Corporation:企業の戦略・SWOT・財務情報
    Cott Corporation - Strategy, SWOT and Corporate Finance Report Summary Cott Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆